Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Journal of Steroid Biochemistry
|
July 1, 1989
Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells
L R Wiseman, A E Wakeling, F E May, et al.
Journal of Steroid Biochemistry
|
March 1, 1990
A comparative study of the interaction of oestradiol and the steroidal pure antioestrogen, ICI 164,384, with the molybdate-stabilized oestrogen receptor
A P Wilson, P J Weatherill, R I Nicholson, et al.
Journal of Steroid Biochemistry
|
January 1, 1988
Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor
P J Weatherill, A P Wilson, R I Nicholson, et al.
International Journal of Cancer
|
May 16, 1995
MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage
J W Wilson, A E Wakeling, I D Morris, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth
C K Osborne, M Jarman, R McCague, et al.
Journal of Steroid Biochemistry
|
December 1, 1989
Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines
F E May, M D Johnson, L R Wiseman, et al.
International Journal of Cancer
|
June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145
H E Jones, C M Dutkowski, D Barrow, et al.
Cancer Research
|
December 15, 1989
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness
E W Thompson, D Katz, T B Shima, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells
L R Wiseman, M D Johnson, A E Wakeling, et al.
The EMBO Journal
|
September 1, 1993
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
F Oberhammer, J W Wilson, C Dive, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Journal of Steroid Biochemistry
|
July 1, 1989
Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells
L R Wiseman, A E Wakeling, F E May, et al.
Journal of Steroid Biochemistry
|
March 1, 1990
A comparative study of the interaction of oestradiol and the steroidal pure antioestrogen, ICI 164,384, with the molybdate-stabilized oestrogen receptor
A P Wilson, P J Weatherill, R I Nicholson, et al.
Journal of Steroid Biochemistry
|
January 1, 1988
Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor
P J Weatherill, A P Wilson, R I Nicholson, et al.
International Journal of Cancer
|
May 16, 1995
MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage
J W Wilson, A E Wakeling, I D Morris, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth
C K Osborne, M Jarman, R McCague, et al.
Journal of Steroid Biochemistry
|
December 1, 1989
Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines
F E May, M D Johnson, L R Wiseman, et al.
International Journal of Cancer
|
June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145
H E Jones, C M Dutkowski, D Barrow, et al.
Cancer Research
|
December 15, 1989
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness
E W Thompson, D Katz, T B Shima, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells
L R Wiseman, M D Johnson, A E Wakeling, et al.
The EMBO Journal
|
September 1, 1993
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
F Oberhammer, J W Wilson, C Dive, et al.
Page
of 6